Figures & data
Table I. Chemotherapy schedules used at Aarhus University Hospital for the treatment of postmolar GTN since 1981.
Table II. Clinical characteristics of 71 patients treated for postmolar gestational trophoblastic neoplasia at Aarhus University Hospital in the period 1981–2011 distributed in three groups according to the line of chemotherapy on which they achieved complete remission. The number total of chemotherapy courses always include the course given for consolidation.
![Figure 1. Overall treatment time in 71 patients with postmolar gestational trophoblastic neoplasia plotted as a function of serum human choriogonadotropin (hCG) measured just before start of chemotherapy by use of LOG-linear regression (R2 = 0.39; p < 0.001). Open circles indicate low-risk (N = 64) and solid circles (N = 7) high-risk patients according to FIGO scoring system.](/cms/asset/9dd1e419-ab3d-459b-8164-e2d66f490b76/ionc_a_1059486_f0001_b.gif)
![Figure 2. The median serum human choriogonadotropin (hCG) level before start of each course of chemotherapy for the 71 patients with postmolar gestational trophoblastic neoplasia divided into three groups according to the line of chemotherapy, by which they obtained complete remission. The total number of chemotherapy courses was median of three, six and eight for final remission on first- (black squares), second- (gray circles) and third-line chemotherapy (open circles), respectively.](/cms/asset/130e3514-49db-4614-afd3-4ba114a7b255/ionc_a_1059486_f0002_b.gif)